173 related articles for article (PubMed ID: 27929666)
1. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
Zhou B; Zhang P; Tang T; Liao H; Zhang K; Pu Y; Chen P; Song Y; Zhang L
BMC Cancer; 2015 May; 15():433. PubMed ID: 26014498
[TBL] [Abstract][Full Text] [Related]
3. Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.
Ghavami A; Fathpour G; Amirghofran Z
Pathol Oncol Res; 2018 Jul; 24(3):653-662. PubMed ID: 28828696
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
5. Association between interleukin-27 gene polymorphisms and susceptibility to allergic rhinitis.
Shen Y; Yuan XD; Hu D; Ke X; Wang XQ; Hu GH; Hong SL; Kang HY
Hum Immunol; 2014 Sep; 75(9):991-5. PubMed ID: 25075448
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer.
Zhang S; Gao X; Wang Y; Jia J; Zhang Q; Ji Z
Tumour Biol; 2015 Sep; 36(10):8207-11. PubMed ID: 25994572
[TBL] [Abstract][Full Text] [Related]
8. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms in IL-27 gene and pre-eclampsia.
Chen P; Gong Y; Pu Y; Wang Y; Zhou B; Song Y; Wang T; Zhang L
Placenta; 2016 Jan; 37():61-4. PubMed ID: 26654512
[TBL] [Abstract][Full Text] [Related]
10. [Association between IL-27 gene polymorphisms and susceptibility to allergic rhinitis].
Ke X; Shen Y; Hu X; Yuan XD; Kang HY; Wang XQ; Hong SL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):684-688. PubMed ID: 29771013
[No Abstract] [Full Text] [Related]
11. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-27 gene variant rs153109 is associated with enhanced cytokine serum levels and susceptibility to Behçet's disease in the Iranian population.
Gholijani N; Daryabor G; Kalantar K; Yazdani MR; Shenavandeh S; Zahed M; Jafarpour Z; Malekmakan MR; Amirghofran Z
Eur Cytokine Netw; 2020 Dec; 31(4):140-146. PubMed ID: 33648922
[TBL] [Abstract][Full Text] [Related]
13. Correlation between
Zhang F; Fan G; Wang X
Biomark Med; 2022 May; 16(7):537-547. PubMed ID: 35362324
[No Abstract] [Full Text] [Related]
14. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
16. The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients.
Ozgen AG; Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
J Endocrinol Invest; 2009 Jun; 32(6):491-4. PubMed ID: 19494710
[TBL] [Abstract][Full Text] [Related]
17. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
18. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
19. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
20. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma.
Xu L; Doan PC; Wei Q; Liu Y; Li G; Sturgis EM
Thyroid; 2012 Jan; 22(1):35-43. PubMed ID: 22136207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
